NORTHERN TRUST CORP - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$570,909
-64.9%
225,656
-7.6%
0.00%
Q2 2023$1,625,746
-58.8%
244,106
+15.3%
0.00%
-100.0%
Q1 2023$3,949,669
-14.7%
211,665
-1.9%
0.00%0.0%
Q4 2022$4,632,764
+88.6%
215,678
+3.8%
0.00%0.0%
Q3 2022$2,456,000
-9.7%
207,873
+0.9%
0.00%0.0%
Q2 2022$2,719,000
-33.2%
205,983
+5.8%
0.00%0.0%
Q1 2022$4,069,000
+3.5%
194,604
+0.7%
0.00%0.0%
Q4 2021$3,930,000
-31.9%
193,307
+1.7%
0.00%0.0%
Q3 2021$5,770,000
+9.8%
190,098
+5.2%
0.00%0.0%
Q2 2021$5,254,000
-26.7%
180,770
+8.9%
0.00%0.0%
Q1 2021$7,165,000
-17.3%
165,996
-11.5%
0.00%
-50.0%
Q4 2020$8,661,000
+5.2%
187,478
-1.3%
0.00%0.0%
Q3 2020$8,232,000
-10.5%
189,871
+9.5%
0.00%0.0%
Q2 2020$9,195,000
+219.0%
173,464
+34.5%
0.00%
+100.0%
Q1 2020$2,882,000
+66.7%
128,924
+9.0%
0.00%
Q4 2019$1,729,000
+120.0%
118,302
+6.0%
0.00%
Q3 2019$786,000
+63.4%
111,573
+154.6%
0.00%
Q2 2019$481,000
+284.8%
43,822
+247.7%
0.00%
Q1 2019$125,00012,6040.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders